What is the best treatment approach for a patient experiencing an Ehlers-Danlos (EDS) flare?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Ehlers-Danlos Syndrome Flares

For EDS flares, avoid opioids and parenteral nutrition, and instead prioritize a multidisciplinary rehabilitative approach centered on physical/occupational therapy with bracing, non-opioid pain management, and treatment of underlying triggers including autonomic dysfunction and gastrointestinal symptoms. 1, 2

Immediate Assessment During Flare

Identify the Flare Trigger

  • Screen for POTS exacerbation by measuring postural vital signs with active stand test (heart rate increase ≥30 beats/min in adults within 10 minutes of standing without orthostatic hypotension), as autonomic dysfunction commonly precipitates symptom flares 2
  • Evaluate for new joint subluxations or dislocations that may be driving acute pain worsening 3
  • Assess for gastrointestinal symptom escalation (nausea, abdominal pain, constipation, bloating), which affects up to 98% of hypermobile EDS patients and frequently worsens during flares 2
  • Rule out mast cell activation if patient presents with episodic multisystem symptoms (flushing, urticaria, wheezing) by obtaining serum tryptase during symptomatic period 2

Critical Pitfall to Avoid

  • Never initiate or escalate opioids during EDS flares, as opioids worsen gastrointestinal dysmotility, increase infection risk, and have shown poor efficacy in this population 1, 4
  • Avoid parenteral nutrition unless life-threatening malnutrition is present, as it should only serve as a temporary bridge to rehabilitative therapies and carries increased infection risk in EDS patients 1

First-Line Acute Flare Management

Most Effective Non-Pharmacologic Interventions

  • Initiate or intensify occupational therapy with bracing, which showed 70% improvement rates in the largest treatment efficacy study—the highest success rate of any intervention 4
  • Apply compression garments for joint stabilization and POTS symptom management 2
  • Implement assistive devices (canes, walkers) to offload affected joints and prevent further subluxations 5

Pharmacologic Pain Management

  • Use NSAIDs as first-line if no contraindications exist 5, 4
  • Add acetaminophen for additional analgesia 4
  • Consider topical analgesics for localized pain 5
  • Trial neuropathic modulators (gabapentin, pregabalin, duloxetine) for neuropathic pain components, though note that 47% of patients report adverse effects requiring dose adjustment 4

POTS-Specific Treatment During Flares

  • Increase fluid intake to 2-3 liters daily and salt intake to 10-12 grams daily as immediate interventions 2
  • Implement compression garments (20-30 mmHg waist-high stockings) 2
  • Consider pharmacologic volume expansion or heart rate control if conservative measures fail 2

Gastrointestinal Symptom Management

  • Optimize oral nutrition with small, frequent meals and gastroparesis diet modifications if upper GI symptoms predominate 1, 2
  • Trial mirtazapine (serotonergic neuromodulator) to increase food tolerance and body weight if significant GI-related weight loss is present 1
  • Avoid elimination diets that may perpetuate or trigger avoidant/restrictive food intake disorder (ARFID), which has significant overlap with EDS 1

Multidisciplinary Team Coordination

Essential Team Members During Flare

  • Pain physician for non-opioid medication optimization and consideration of interventional procedures 6
  • Physical/occupational therapist for immediate joint stabilization strategies and proprioceptive training 4, 6, 3
  • Pain psychologist for cognitive behavioral therapy addressing kinesiophobia, anxiety, and central sensitization 6, 7
  • Gastroenterologist if GI symptoms are prominent or refractory 2
  • Cardiologist or autonomic specialist if POTS symptoms are severe 2

Psychosocial Interventions

  • Initiate or intensify cognitive behavioral therapy focusing on pain catastrophizing, kinesiophobia, and anxiety, which significantly burden EDS patients and worsen pain perception 6, 7
  • Provide pain education about central sensitization mechanisms and the multifactorial nature of EDS pain 6, 7
  • Teach coping and relaxation strategies as part of pain self-management 6

Emerging Therapies with Promising Evidence

  • Low-dose naltrexone has shown promising effects for decreasing pain and increasing quality of life 7
  • Transcutaneous electrical nerve stimulation (TENS) units demonstrate benefit for pain reduction 7
  • Trigger point injections for localized myofascial pain 7
  • Laser therapy shows emerging evidence for pain relief 7
  • Medical marijuana was rated as extremely helpful by 10-24% of users in patient surveys, though this represents non-prescribed therapy use 8

When Interventional Procedures May Be Considered

  • Selected patients may benefit from pain interventions to decrease pain intensity, contrary to historical concerns about local anesthetic resistance in EDS 6
  • Ensure procedures are performed at centers with EDS expertise given tissue fragility concerns 5

Long-Term Flare Prevention Strategy

  • Maintain regular physical therapy focusing on muscle strengthening to compensate for joint laxity and prevent subluxations 4, 3, 7
  • Continue compression garments and bracing for joint protection during activities 2, 4
  • Optimize cardiovascular conditioning through graded exercise programs to improve POTS symptoms 2
  • Address sleep disturbances and fatigue, which contribute to pain amplification 7
  • Maintain adequate vitamin D and calcium supplementation for bone health 5

What NOT to Do During EDS Flares

  • Do not prescribe or escalate opioids, as they worsen GI dysmotility, increase infection risk, and show poor long-term efficacy 1, 4
  • Do not initiate parenteral nutrition unless life-threatening malnutrition exists, and only as temporary bridge to rehabilitative therapy 1
  • Do not perform invasive vascular procedures in vascular EDS patients due to fatal complication risk 2, 5
  • Do not recommend prolonged bed rest, which worsens deconditioning and POTS symptoms 2
  • Do not dismiss psychological comorbidities, as anxiety and panic disorders significantly amplify pain burden 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ehlers-Danlos Syndrome Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pain management in the Ehlers-Danlos syndromes.

American journal of medical genetics. Part C, Seminars in medical genetics, 2017

Guideline

Management of Avascular Necrosis of the Hip in Ehlers-Danlos Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.